-Robert E Ware Researcher Activity Profile

Research Author Detailed Information 

Robert E Ware Publication Rate By Year

Robert E Ware has published 1 paper(s) in 1999, 1 paper(s) in 2004, 8 paper(s) in 2007, 4 paper(s) in 2008, for a total of 14 research publications in total.

Robert E Re Ware Author Information

LAST NAME: ware

FIRST NAME: Robert E

INITIALS: re

AFFILIATION:

Papers

Robert E Ware's Publication Record

1. Usefulness of fluorine-18 fluorodeoxyglucose positron emission tomography in patients with a residual structural abnormality after definitive treatment for squamous cell carcinoma of the head and neck. Year Published: 2004
The Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
2. Quantitative analysis of Howell-Jolly bodies in children with sickle cell disease. Year Published: 2007
Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA. virginia.harrod@stjude.org
3. Beta-thalassemia intermedia due to compound heterozygosity for two beta-globin gene promoter mutations, including a novel TATA box deletion. Year Published: 2007
Hemoglobin Diagnostic Reference Laboratory, Boston Medical Center, Boston, Massachusetts, USA.
4. Preservation of spleen and brain function in children with sickle cell anemia treated with hydroxyurea. Year Published: 2007
Department of Hematology, Comprehensive Sickle Cell Center, St. Jude Children's Research Hospital, Memphis, Tennessee, USA. jane.hankins@stjude.org
5. beta-thalassemia intermedia due to compound heterozygosity for two beta-globin gene promoter mutations, including a novel TATA box deletion. Year Published: 2007
Hemoglobin Diagnostic Reference Laboratory, Boston Medical Center, Boston, Massachusetts.
6. Preservation of spleen and brain function in children with sickle cell anemia treated with hydroxyurea. Year Published: 2007
Department of Hematology, Comprehensive Sickle Cell Center, St. Jude Children's Research Hospital, Memphis, Tennessee.
7. TCD response to hydroxyurea therapy. Year Published: 2008
8. Beta-thalassemia intermedia due to compound heterozygosity for two beta-globin gene promoter mutations, including a novel TATA box deletion. Year Published: 2007
Hemoglobin Diagnostic Reference Laboratory, Boston Medical Center, Boston, Massachusetts, USA.
9. Preservation of spleen and brain function in children with sickle cell anemia treated with hydroxyurea. Year Published: 2007
Department of Hematology, Comprehensive Sickle Cell Center, St. Jude Children's Research Hospital, Memphis, Tennessee, USA. jane.hankins@stjude.org
10. Defective binding of factor XI-N248 to activated human platelets. Year Published: 2007
Department of Pathology, Vanderbilt University, Nashville, TN 37232-6305, USA.
11. MR features of soft-tissue abnormalities due to acute marrow infarction in five children with sickle cell disease. Year Published: 1999
Department of Radiology, Duke University Medical Center, Durham, NC 27710, USA.
12. Partial splenectomy for children with congenital hemolytic anemia and massive splenomegaly. Year Published: 2008
Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA.
13. Preface. Year Published: 2008
Center for Cancer and Blood Disorders, Children's National Medical Center, Washington, DC, USA; Georgetown University, Washington, DC, USA.
14. Hydroxyurea for children with sickle cell disease. Year Published: 2008
Harvard Medical School, Boston, MA, USA; Division of Hematology/Oncology, Children's Hospital Boston, Fegan 704, 300 Longwood Avenue, Boston, MA 02115, USA.